Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.15M Buy
+27,386
New +$6.82M 0.11% 197
2025
Q2
Sell
-1,583
Closed -$354K 3037
2025
Q1
$354K Sell
1,583
-283
-15% -$66.1K 0.02% 1282
2024
Q4
$427K Buy
1,866
+631
+51% +$152K 0.04% 908
2024
Q3
$301K Sell
1,235
-10,069
-89% -$2.25M 0.02% 1180
2024
Q2
$2.16M Buy
11,304
+7,478
+195% +$1.52M 0.19% 109
2024
Q1
$758K Buy
+3,826
New +$701K 0.1% 261
2023
Q1
Sell
-4,787
Closed -$996K 1607
2022
Q4
$996K Buy
+4,787
New +$1.05M 0.21% 88
2022
Q3
Sell
-1,695
Closed -$355K 1345
2022
Q2
$355K Buy
+1,695
New +$361K 0.15% 218
2021
Q3
Sell
-1,456
Closed -$359K 1010
2021
Q2
$359K Buy
+1,456
New +$306K 0.12% 288

Other funds holding RMD

XTX Topco's RMD Position: Q1 2026 in Review

XTX Topco opened a new position in ResMed (RMD) in Q1 2026: 27,386 shares worth $6.15M. The stake represents 0.11% of the portfolio and ranks #197 among its holdings. This is a return to the name: XTX Topco previously reported a position in RMD as recently as Q1 2025.

XTX Topco first reported a position in RMD in Q2 2021 and has held it in 9 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • XTX Topco held 27,386 shares of ResMed worth $6.15M as of Q1 2026.
  • ResMed was a new XTX Topco position in Q1 2026.
  • ResMed made up 0.11% of XTX Topco's portfolio in Q1 2026, its #197 holding.
  • XTX Topco first reported a position in ResMed in Q2 2021 and has held it in 9 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.